Trial intelligence / Profile preview

Genetic predictors of escitalopram response in adults with panic disorder

2007-002649-19Phase 4Completed

Sponsor
Tartu University Hospital
Start
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of escitalopram in panic disorder, sponsored by Tartu University Hospital. Primary endpoints: Treatment response by Panic Disorder Severity Scale, Clinical severity by Panic Disorder Severity Scale and 2 more. Started Dec 2009; status: completed.

02

Drugs

escitalopram
03

Conditions

panic disorder

Beyond the preview

Go deeper on 2007-002649-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002649-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call